IL17A and endothelial dysfunction: Sustained inflammatory signaling activates pathways involving tumor necrosis factor α (TNFα), interleukin (IL)-17, and IL-23, leading to endothelial dysfunction, oxidative stress, and the advancement of atherosclerosis [4].